DRUG RESISTANCE AMONG MALARIA AND OTHER PARASITES, Infectious Disease Clinics of North America, vol.11, issue.4, pp.969-987, 1997. ,
DOI : 10.1016/S0891-5520(05)70400-1
Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein, Journal of Experimental Medicine, vol.180, issue.1, pp.389-393, 1994. ,
DOI : 10.1084/jem.180.1.389
A recombinant baculovirus 42-kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria, Infect. Immun, vol.64, pp.253-261, 1996. ,
Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1, Molecular and Biochemical Parasitology, vol.60, issue.2, pp.303-311, 1993. ,
DOI : 10.1016/0166-6851(93)90141-J
Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP119 expressed in distinct bacterial vectors, Vaccine, vol.20, issue.3-4, pp.385-396, 2001. ,
DOI : 10.1016/S0264-410X(01)00359-0
Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species., Proceedings of the National Academy of Sciences, vol.88, issue.9, pp.4030-4034, 1991. ,
DOI : 10.1073/pnas.88.9.4030
Vaccine Efficacy of Recombinant Plasmodium falciparum Merozoite Surface Protein 1 in Malaria-Naive, -Exposed, and/or -Rechallenged Aotus vociferans Monkeys, Infection and Immunity, vol.68, issue.3, pp.1418-1427, 2000. ,
DOI : 10.1128/IAI.68.3.1418-1427.2000
Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy binding protein, Infect. Immun, vol.65, pp.2772-2777, 1997. ,
Surface antigens of malaria merozoites. A high molecular weight precursor is processed to an 83,000 mol wt form expressed on the surface of Plasmodium falciparum merozoites, Journal of Experimental Medicine, vol.158, issue.5, pp.1647-1653, 1983. ,
DOI : 10.1084/jem.158.5.1647
The isotype composition and avidity of naturally acquired anti-Plasmodium falciparum antibodies: differential patterns in clinically immune Africans and Amazonian patients, Am. J. Trop. Med. Hyg, vol.55, pp.315-323, 1996. ,
Sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-1 (MSP-1) of Plasmodium falciparum, Gene, vol.304, pp.65-75, 2003. ,
DOI : 10.1016/S0378-1119(02)01180-0
Plasmodium vivax: Merozoites, invasion of reticulocytes and considerations for malaria vaccine development, Parasitology Today, vol.12, issue.1, pp.20-29, 1996. ,
DOI : 10.1016/0169-4758(96)80641-7
Epidermal growth factor-like motifs 1 and 2 of Plasmodium vivax merozoite surface protein 1 are critical domains in erythrocyte invasion, Biochemical and Biophysical Research Communications, vol.320, issue.2, pp.563-570, 2004. ,
DOI : 10.1016/j.bbrc.2004.06.008
Recent Primary Toxoplasma Infection Indicated by a Low Avidity of Specific IgG, Journal of Infectious Diseases, vol.159, issue.4, pp.736-740, 1989. ,
DOI : 10.1093/infdis/159.4.736
A malaria merozoite surface protein (MSP1)-structure, processing and function, Mem??rias do Instituto Oswaldo Cruz, vol.87, pp.37-42, 1992. ,
DOI : 10.1590/S0074-02761992000700004
Genetic diversity of Plasmodium vivax isolates from Azerbaijan, Malaria Journal, vol.3, issue.1, p.40, 2004. ,
DOI : 10.1186/1475-2875-3-40
Analysis of Plasmodium vivax merozoite surface protein-1 gene sequences from resurgent Korean isolates, Am. J. Trop. Med. Hyg, vol.62, pp.261-265, 2000. ,
Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax, Parasitol. Res, vol.92, pp.384-389, 2004. ,
The neglected burden of Plasmodium vivax malaria, Am. J. Trop. Med. Hyg, vol.64, pp.97-106, 2001. ,
IgG isotype to C-terminal 19???kDa of Plasmodium vivax merozoite surface protein 1 among subjects with different levels of exposure to malaria in Brazil, Parasitology Research, vol.28, issue.6, pp.420-426, 2005. ,
DOI : 10.1007/s00436-005-1314-x
A Reduced Risk of Infection with Plasmodium vivax and Clinical Protection against Malaria Are Associated with Antibodies against the N Terminus but Not the C Terminus of Merozoite Surface Protein 1, Infection and Immunity, vol.74, issue.5, pp.2726-2733, 2006. ,
DOI : 10.1128/IAI.74.5.2726-2733.2006
Species That Cause Human Malaria, The Journal of Infectious Diseases, vol.183, issue.11, pp.1653-1661, 2001. ,
DOI : 10.1086/320707
Naturally Acquired Antibody Responses to the C-Terminal Region of Merozoite Surface Protein 1 of Plasmodium vivax in Korea, Clinical and Vaccine Immunology, vol.8, issue.1, pp.14-20, 2001. ,
DOI : 10.1128/CDLI.8.1.14-20.2001
IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria, Southeast Asian J. Trop. Med. Public. Health, vol.38, pp.1-7, 2007. ,
Mosaic organization and heterogeneity in frequency of allelic re-combination of the Plasmodium vivax merozoite surface protein-1 locus, Proc. Natl. Acad. Sci. U.S.A. 99, pp.16348-16353, 2002. ,
Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes, Vaccine, vol.20, issue.9-10, pp.1331-1339, 2002. ,
DOI : 10.1016/S0264-410X(01)00472-8
Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity., Proceedings of the National Academy of Sciences, vol.92, issue.5, pp.1257-1261, 1995. ,
DOI : 10.1073/pnas.92.5.1257
Comparison of Immunogenicities of Recombinant Plasmodium vivax Merozoite Surface Protein 1 19- and 42-Kilodalton Fragments Expressed in Escherichia coli, Infection and Immunity, vol.72, issue.10, pp.5775-5782, 2004. ,
DOI : 10.1128/IAI.72.10.5775-5782.2004
Risk of Plasmodium vivax malaria reintroduction in Uzbekistan: genetic characterization of parasites and status of potential malaria vectors in the Surkhandarya region, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.98, issue.10, pp.585-592, 2004. ,
DOI : 10.1016/j.trstmh.2004.01.003
High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction, Molecular and Biochemical Parasitology, vol.61, issue.2, pp.315-320, 1993. ,
DOI : 10.1016/0166-6851(93)90077-B
Acquired immune responses to the N-and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria, Infect. Immun, vol.65, pp.1606-1614, 1997. ,
Longevity of naturally acquired antibody responses to the N-and C-terminal regions of Plasmodium vivax merozoite surface protein 1, Am. J. Trop. Med. Hyg, vol.60, pp.357-363, 1999. ,
Cross sectional study reveals a high percentage of asymptomatic Plasmodium vivax infection in the Amazon Rio Negro area, Brazil, Revista do Instituto de Medicina Tropical de S??o Paulo, vol.49, issue.3, pp.159-164, 2007. ,
DOI : 10.1590/S0036-46652007000300005
Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii, Infect. Immun, vol.65, pp.3032-3036, 1997. ,
Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum, Journal of Molecular Biology, vol.195, issue.2, pp.273-287, 1987. ,
DOI : 10.1016/0022-2836(87)90649-8
Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum11Edited by J. A. Wells, Journal of Molecular Biology, vol.307, issue.5, pp.1381-1394, 2001. ,
DOI : 10.1006/jmbi.2001.4574
Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka, International Journal for Parasitology, vol.37, issue.2, pp.199-208, 2007. ,
DOI : 10.1016/j.ijpara.2006.09.002
Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant, Infect. Immun, vol.67, pp.342-349, 1999. ,
Detection of malaria parasites by nested PCR in south-eastern, Iran: Evidence of highly mixed infections in Chahbahar district, Malar. J, vol.1, issue.2, 2002. ,
Molecular evidence of mixed P. vivax and P. falciparum infections in northern Islamic Republic of Iran, East. Mediterr. Health. J, vol.10, pp.336-342, 2004. ,
Population structure analysis of Iranian Plasmodium vivax in areas with different malaria endemicity, Am. J. Trop. Med. Hyg, vol.74, pp.394-400, 2006. ,
Short report: analysis of naturally acquired antibody responses to the 19- kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey. Am. J. Trop. Med. Hyg, vol.78, pp.729-732, 2008. ,